Hematology and Oncology (Cancer) | More

Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics Director, Center for Clinical Cancer Genetics & Global Health

A clinically integrated network of physicians and providers employed by UChicago Medicine who offer care in inpatient, community, ambulatory, acute care or extended care settings.

Close
855-702-8222 Request an Appointment Refer a Patient
Olufunmilayo I. Olopade, MD, FACP

Olufunmilayo I. Olopade, MD, FACP, is an expert in cancer risk assessment and individualized treatment for the most aggressive forms of breast cancer, having developed novel management strategies based on an understanding of the altered genes in individual patients. She stresses comprehensive risk reducing strategies and prevention in high-risk populations, as well as earlier detection through advanced imaging technologies. 

Dr. Olopade is international renowned for her expertise in breast cancer, and her research has advanced early detection, treatment and prevention of breast cancer in high risk women. A distinguished scholar and mentor, Olopade has received numerous honors and awards including honorary degrees from six universities and a 2005 MacArthur Fellowship (“Genius grant”) for “translating findings on the molecular genetics of breast cancer in African and African-American women into innovative clinical practices in the United States and abroad.” She serves as a director on several Civic and Corporate Boards.

Dr. Olopade has received numerous honors and awards, including honorary degrees from North Central, Dominican, Bowdoin and Princeton universities. She is also a recipient of the Doris Duke Distinguished Clinical Scientist and Exceptional Mentor Award, an American Cancer Society Clinical Research Professorship, a MacArthur Foundation "Genius" Fellowship and Officer of the Order of the Niger Award. Dr. Olopade is an elected member of the American Academy of Arts and Sciences and the American Philosophical Society. She currently serves on the board of directors for the American Board of Internal Medicine, the National Cancer Advisory Board, Susan G. Komen for the Cure, Cancer IQ and the Lyric Opera.

Areas of Expertise

Medical Education

  • University of Ibadan College of Medicine, Nigeria

Internship

  • Cook County Hospital, Chicago

Residency

  • Cook County Hospital, Chicago

Fellowship

  • University of Chicago Medicine

Memberships & Medical Societies

  • American Board of Internal Medicine
  • Nigerian Medical Association
  • National Cancer Advisory Board
  • Human Genome Organization
  • Association of American Professors
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society of Breast Disease
  • American Society for Preventative Oncology
  • American Society for Clinical Investigation
  • American Philosophical Society
  • American College of Physicians
  • American Association for the Advancement of Science
  • American Association for Cancer Research
  • Women in Cancer Research
  • Institute of Medicine
  • Aetna POS
  • Aetna HMO
  • Aetna PPO
  • BCBS Blue Precision HMO
  • BCBS HMO (HMOI)
  • BCBS PPO
  • Cigna HMO
  • Cigna POS
  • Cigna PPO
  • CountyCare
  • Coventry Health Plan PPO
  • Great West PPO
  • Illinicare
  • Medicare
  • Multiplan PPO
  • PHCS PPO
  • United Choice / Choice Plus
  • United Options (PPO)
  • United Select (HMO & EPO)
  • United W500 Emergent Wrap
To Request an Appointment

Duchossois Center for Advanced Medicine (DCAM) - Hyde Park

Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park or call UCM Connect at 1-888-824-0200

To Refer a Patient

Refer a Patient or call UCM Connect at 1-888-824-0200

At a Glance

Practicing Since1980

Board Certifications

  • Medical Oncology
  • Hematology
  • Internal Medicine

Languages Spoken

  • Yoruba
  • English
Video placeholder
Breast Cancer Screening - Annual vs Personalized

A longstanding debate has stymied the medical community about when and how often women should be screened for breast cancer. The WISDOM study will assess whether personalized screening is as safe, effective and accepted compared to annual screening.

Watch Video